Masafumi Ikeda

ORCID: 0000-0002-4050-2086

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma”.

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma

New England Journal of Medicine(2020)10.1056/nejmoa1915745

N/A

1.3DataRank · unranked

7029 citations

Shukui Qin, Masafumi Ikeda, Peter R. Galle, Michel Ducreux, Tae-You Kim +19 more

E7386 Enhances Lenvatinib’s Antitumor Activity in Preclinical Models and Human Hepatocellular Carcinoma

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-0725

N/A

0.282DataRank · unranked

5 citations

Albert Gris‐Oliver, Ugne Balaseviciute, Alka A. Potdar, Takayuki Kimura, Jialing Shen +21 more

JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis

Journal of Gastroenterology(2021)10.1007/s00535-021-01827-7

N/A

0DataRank · unranked

163 citations

Toshihiko Masui, Izumi Komoto, Ryuichiro Doi, R. Yoshiyuki Osamura, Akihiro Sakurai +45 more